Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Potential Deployment Strategies for Oral Delivery of Vaccines for Cervids.

Transboundary and emerging diseases·2026
Same author

An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism.

Nature·2026
Same author

Mapping the inter- and intra-genic codon-usage landscape in <i>Homo sapiens</i>.

NAR genomics and bioinformatics·2026
Same author

Autism data sharing: Benefits, challenges, and recommendations.

PLOS digital health·2026
Same author

Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy.

Neurology·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Apr 16, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.8K

EpIC: a rational pipeline for epitope immunogenicity characterization.

Kristen Marciniuk1, Brett Trost2, Scott Napper1

  • 1Department of Biochemistry, University of Saskatchewan, Saskatoon, SK, S7N 5E5 Canada, Vaccine and Infectious Disease Organization-International Vaccine Centre, University of Saskatchewan, Saskatoon, SK, S7N 5E3 Canada and.

Bioinformatics (Oxford, England)
|March 10, 2015
PubMed
Summary

We developed EpIC, a new program for predicting peptide immunogenicity. EpIC enables high-throughput screening of peptide vaccine candidates by analyzing B-cell epitopes in native proteins, improving efficiency and reducing costs.

More Related Videos

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

7.5K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

10.2K

Related Experiment Videos

Last Updated: Apr 16, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.8K
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

7.5K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

10.2K

Area of Science:

  • Vaccine development
  • Immunology
  • Bioinformatics

Background:

  • Peptide-based vaccines require optimized immunogenicity for effective targeting.
  • Current screening methods involve costly and low-throughput animal trials.

Purpose of the Study:

  • To present EpIC, a computational tool for high-throughput prediction of peptide immunogenicity.
  • To enable rational selection of immunogenicity-optimized epitopes for vaccine design.

Main Methods:

  • EpIC analyzes endogenous B-cell epitopes within native protein sequences.
  • The program predicts peptide immunogenicity based on epitope occurrence.

Main Results:

  • EpIC facilitates high-throughput prediction of peptide immunogenicity.
  • This aids in the rational selection of vaccine candidates.

Conclusions:

  • EpIC offers an improved approach to screening peptide vaccine candidates.
  • The tool streamlines the optimization of immunogenicity for peptide vaccines.